In addition to the combination, pegylated interferon alfa-2β (PEG IFN-α-2β) along with the standard of care (SOC) enabled a faster viral reduction in patients with moderate COVID-19 than with standard care alone (235). This evidence concerns the gene IFNA2 and COVID-19.